Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer

The intractability of non-small cell lung cancer (NSCLC) to multimodality treatments plays a large part in its extremely poor prognosis. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cytokine for selective induction of apoptosis in cancer cells; however, many NSCLC c...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Liangran, Fan, Li, Ren, Jinfeng, Pang, Zhiqing, Ren, Yulong, Li, Jingwei, Wen, Ziyi, Qian, Yong, Zhang, Lin, Ma, Hang, Jiang, Xinguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356168/
https://www.ncbi.nlm.nih.gov/pubmed/22619505
http://dx.doi.org/10.2147/IJN.S24711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356168/
https://www.ncbi.nlm.nih.gov/pubmed/22619505
http://dx.doi.org/10.2147/IJN.S24711

Ejemplares similares